Find Repirinast manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 73080-51-0, Romet, My-5116, Isopentyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4h-pyrano[3,2-c]quinoline-2-carboxylate, 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6h-pyrano[3,2-c]quinoline-2-carboxylate, 4k8ka8b61g
Molecular Formula
C20H21NO5
Molecular Weight
355.4  g/mol
InChI Key
NFQIAEMCQGTTIR-UHFFFAOYSA-N
FDA UNII
4K8KA8B61G

Repirinast
1 2D Structure

Repirinast

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-methylbutyl 7,8-dimethyl-4,5-dioxo-6H-pyrano[3,2-c]quinoline-2-carboxylate
2.1.2 InChI
InChI=1S/C20H21NO5/c1-10(2)7-8-25-20(24)15-9-14(22)16-18(26-15)13-6-5-11(3)12(4)17(13)21-19(16)23/h5-6,9-10H,7-8H2,1-4H3,(H,21,23)
2.1.3 InChI Key
NFQIAEMCQGTTIR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C2=C(C=C1)C3=C(C(=O)C=C(O3)C(=O)OCCC(C)C)C(=O)N2)C
2.2 Other Identifiers
2.2.1 UNII
4K8KA8B61G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline -2-carboxylate

2. My 5116

3. My-5116

2.3.2 Depositor-Supplied Synonyms

1. 73080-51-0

2. Romet

3. My-5116

4. Isopentyl 7,8-dimethyl-4,5-dioxo-5,6-dihydro-4h-pyrano[3,2-c]quinoline-2-carboxylate

5. 3-methylbutyl 7,8-dimethyl-4,5-dioxo-6h-pyrano[3,2-c]quinoline-2-carboxylate

6. 4k8ka8b61g

7. Repirinastum

8. Repirinastum [inn-latin]

9. 3-methylbutyl 5-hydroxy-7,8-dimethyl-4-oxopyrano[3,2-c]quinoline-2-carboxylate

10. Repirinast [usan:inn:jan]

11. Brn 4267921

12. Unii-4k8ka8b61g

13. Repirinast-[d4]

14. Isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate

15. Romet (tn)

16. Repirinast [mi]

17. Repirinast [inn]

18. Repirinast [jan]

19. Repirinast [usan]

20. Repirinast [mart.]

21. Isopentyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4h-pyrano(3,2-c)quinoline-2-carboxylate

22. Repirinast [who-dd]

23. Schembl29997

24. Repirinast (jan/usan/inn)

25. Chembl2105300

26. Chebi:32092

27. Dtxsid10223349

28. Zinc538285

29. Bcp16315

30. Ex-a3508

31. My5116

32. Akos016014130

33. Ac-5020

34. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, 3-methylbutyl Ester

35. 4h-pyrano(3,2-c)quinoline-2-carboxylic Acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, Isopentyl Ester

36. Db-055720

37. Hy-109544

38. Cs-0031286

39. Ft-0630818

40. D01890

41. 080r510

42. A837709

43. Q7314016

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 355.4 g/mol
Molecular Formula C20H21NO5
XLogP33.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass355.14197277 g/mol
Monoisotopic Mass355.14197277 g/mol
Topological Polar Surface Area81.7 Ų
Heavy Atom Count26
Formal Charge0
Complexity690
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)


Histamine Antagonists

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty